Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1956 1
1958 1
1962 4
1963 2
1964 5
1965 3
1966 1
1967 1
1968 5
1969 10
1970 8
1971 7
1972 17
1973 8
1974 14
1975 22
1976 16
1977 6
1978 9
1979 16
1980 10
1981 14
1982 7
1983 9
1984 8
1985 3
1986 8
1987 8
1988 6
1989 17
1990 19
1991 11
1992 10
1993 12
1994 12
1995 12
1996 9
1997 8
1998 7
1999 9
2000 8
2001 17
2002 15
2003 21
2004 17
2005 16
2006 31
2007 24
2008 26
2009 25
2010 30
2011 40
2012 47
2013 29
2014 49
2015 46
2016 52
2017 41
2018 43
2019 46
2020 49
2021 63
2022 43
2023 18

Text availability

Article attribute

Article type

Publication date

Search Results

1,083 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19: JACC Review Topic of the Week.
Abraham S, Nohria A, Neilan TG, Asnani A, Saji AM, Shah J, Lech T, Grossman J, Abraham GM, McQuillen DP, Martin DT, Sax PE, Dani SS, Ganatra S. Abraham S, et al. Among authors: abraham gm. J Am Coll Cardiol. 2022 Nov 15;80(20):1912-1924. doi: 10.1016/j.jacc.2022.08.800. Epub 2022 Oct 12. J Am Coll Cardiol. 2022. PMID: 36243540 Free PMC article. Review.
Towards clinical utility of polygenic risk scores.
Lambert SA, Abraham G, Inouye M. Lambert SA, et al. Among authors: abraham g. Hum Mol Genet. 2019 Nov 21;28(R2):R133-R142. doi: 10.1093/hmg/ddz187. Hum Mol Genet. 2019. PMID: 31363735 Review.
Tuberculosis and COVID-19 Co-infection: An Updated Review.
Mishra A, George AA, Sahu KK, Lal A, Abraham G. Mishra A, et al. Among authors: abraham g. Acta Biomed. 2020 Nov 10;92(1):e2021025. doi: 10.23750/abm.v92i1.10738. Acta Biomed. 2020. PMID: 33682808 Free PMC article. Review.
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
Ziegler CGK, Miao VN, Owings AH, Navia AW, Tang Y, Bromley JD, Lotfy P, Sloan M, Laird H, Williams HB, George M, Drake RS, Christian T, Parker A, Sindel CB, Burger MW, Pride Y, Hasan M, Abraham GE 3rd, Senitko M, Robinson TO, Shalek AK, Glover SC, Horwitz BH, Ordovas-Montanes J. Ziegler CGK, et al. Among authors: abraham ge 3rd. Cell. 2021 Sep 2;184(18):4713-4733.e22. doi: 10.1016/j.cell.2021.07.023. Epub 2021 Jul 23. Cell. 2021. PMID: 34352228 Free PMC article.
The impact of communication style on patient satisfaction.
Trant AA, Szekely B, Mougalian SS, DiGiovanna MP, Sanft T, Hofstatter E, Silber A, Adelson KB, Chagpar A, Killelea B, Horowitz N, Lannin D, Park T, Corso M, Abraham G, Pollard-Murphy K, Sturrock T, Knill-Selby E, Western A, Servodidio C, Tasoulis MK, Healy B, Hatzis C, Pusztai L. Trant AA, et al. Among authors: abraham g. Breast Cancer Res Treat. 2019 Jul;176(2):349-356. doi: 10.1007/s10549-019-05232-w. Epub 2019 Apr 25. Breast Cancer Res Treat. 2019. PMID: 31025271
Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention.
Inouye M, Abraham G, Nelson CP, Wood AM, Sweeting MJ, Dudbridge F, Lai FY, Kaptoge S, Brozynska M, Wang T, Ye S, Webb TR, Rutter MK, Tzoulaki I, Patel RS, Loos RJF, Keavney B, Hemingway H, Thompson J, Watkins H, Deloukas P, Di Angelantonio E, Butterworth AS, Danesh J, Samani NJ; UK Biobank CardioMetabolic Consortium CHD Working Group. Inouye M, et al. Among authors: abraham g. J Am Coll Cardiol. 2018 Oct 16;72(16):1883-1893. doi: 10.1016/j.jacc.2018.07.079. J Am Coll Cardiol. 2018. PMID: 30309464 Free PMC article.
Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study.
Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A, Islam N, Bravo RF, Aleckovic-Halilovic M, Zou H, Zhang L, Gouda Z, Tchokhonelidze I, Abraham G, Mahdavi-Mazdeh M, Gallieni M, Codreanu I, Togtokh A, Sharma SK, Koirala P, Uprety S, Ulasi I, Remuzzi G. Ene-Iordache B, et al. Among authors: abraham g. Lancet Glob Health. 2016 May;4(5):e307-19. doi: 10.1016/S2214-109X(16)00071-1. Lancet Glob Health. 2016. PMID: 27102194 Free article.
[Self-confidence].
Abraham G. Abraham G. Rev Med Suisse. 2014 Nov 26;10(452):2296. Rev Med Suisse. 2014. PMID: 25562989 French. No abstract available.
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Patil VM, Noronha V, Joshi A, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, Mahimkar M, Juvekar S, Arya S, Mahajan A, Agarwal A, Purandare N, Rangarajan V, Balaji A, Chaudhari SV, Banavali S, Kannan S, Bhattacharjee A, D'Cruz AK, Chaturvedi P, Pai PS, Chaukar D, Pantvaidya G, Nair D, Nair S, Deshmukh A, Thiagarajan S, Mathrudev V, Manjrekar A, Dhumal S, Maske K, Bhelekar AS, Nawale K, Chandrasekharan A, Pande N, Goel A, Talreja V, Simha V, Srinivas S, Swami R, Vallathol DH, Dsouza H, Shrirangwar S, Turkar S, Abraham G, Thanky AH, Patel U, Pandey MK, Prabhash K. Patil VM, et al. Among authors: abraham g. Cancer. 2019 Sep 15;125(18):3184-3197. doi: 10.1002/cncr.32179. Epub 2019 May 31. Cancer. 2019. PMID: 31150120 Free article. Clinical Trial.
1,083 results